Pent-up private Wegovy demand prompts UK availability concerns
Britain is Novo's fifth market for Wegovy
*Read moreThu, 26th Sep 2019 10:24
Britain is Novo's fifth market for Wegovy
*Read moreBritain is Novo's fifth market for Wegovy
*Read moreBritain is Novo's fifth market for Wegovy
*Read moreBritain is Novo's fifth market for Wegovy
*Read moreNovo says Wegovy launch in UK 'controlled and limited'
*Read moreLONDON, Sept 4 (Reuters) - British private insurer Aviva has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the UK on Monday.
Read moreGlencore among top losers on FTSE 100
*Read more(Alliance News) - Direct Line Insurance Group PLC on Wednesday said it has appointed former Aviva PLC UK boss Adam Winslow as its new chief executive officer, succeeding interim CEO Jon Greenwood.
Read more(Alliance News) - Stocks in London are called up on Wednesday, in hopes markets will extend Tuesday's rally.
Read more(Sharecast News) - Direct Line said it had appointed Adam Winslow as chief executive to succeed Jon Greenwood who has been acting CEO since January.
Read moreAviva PLC - London-based insurer - Chief Executive Officer Amanda Blanc buys 26,500 shares at GBP3.8119 each, worth GBP101,015, in London on Wednesday.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:
Read moreBlue-chip FTSE 100 snaps seven-day losing streak
*Read more